α-Amylase-IN-12
α-Amylase-IN-12 (Compound 5e) is an α-amylase inhibitor (IC50: 0.15 mM) with a mixed inhibition. α-Amylase-IN-12 has an IC50 of 9.40 mM against α-glucosidase. α-Amylase-IN-12 promotes glucose uptake in yeast cells and exhibits significant antiglycation activity at high concentrations. α-Amylase-IN-12 can be used for the research of diabetes[1].
Product Specifications
CAS Number
[1799667-33-6]
UNSPSC
12352005
Target
Amylases; Glycosidase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
O=C(OC(C1=CC=CC=C1)=N/2)C2=C\C3=CC=C(O)C(O)=C3
Molecular Formula
C16H11NO4
Molecular Weight
281.26
References & Citations
[1]Jayasinghe R N, et al. Evaluation of In Silico and In Vitro Antidiabetic Properties of 4- (Hydroxysubstituted Arylidene) -2-Phenyloxazol-5 (4 H) -one Derivatives. ACS Omega, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1339821-01 0.02 mg (E-Coli)
Recombinant Human Zinc finger HIT domain-containing protein 2 (ZNHIT2)
Ask
View Details 
MBS1339821-02 0.02 mg (Yeast)
Recombinant Human Zinc finger HIT domain-containing protein 2 (ZNHIT2)
Ask
View Details 
MBS1339821-03 0.1 mg (E-Coli)
Recombinant Human Zinc finger HIT domain-containing protein 2 (ZNHIT2)
Ask
View Details 
MBS1339821-04 0.1 mg (Yeast)
Recombinant Human Zinc finger HIT domain-containing protein 2 (ZNHIT2)
Ask
View Details MBS1339821-05 0.02 mg (Baculovirus)
Recombinant Human Zinc finger HIT domain-containing protein 2 (ZNHIT2)
Ask
View Details MBS1339821-06 0.02 mg (Mammalian-Cell)
Recombinant Human Zinc finger HIT domain-containing protein 2 (ZNHIT2)
Ask
View Details